Ads
related to: anti-cancer treatment
Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoPhase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment ...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 3 days agoCaroline Germa said: "In this population, the triple combo treatment delivered significantly better...
BioInvent to Host Virtual KOL Event to Highlight Recently Presented Efficacy Data from BioInvent's...
Digital Journal· 11 hours agoLUND, SWEDEN / ACCESSWIRE / May 30, 2024 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...
Unlock Holistic Wellness with Spirulina Mater: The Natural Superfood for Optimal Health and Vitality
Digital Journal· 9 hours agoAnti-Cancer Properties: Preliminary research indicates it may reduce tumor size and inhibit cancer cell growth. ...Administration. This ...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 6 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 6 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in...
FOX 4 Kansas City· 3 days ago("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...
WROC Rochester· 3 days agoNew safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class ...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 10 hours agoIncyte has a collaboration and license agreement with Syndax to develop and commercialize...
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
InvestorPlace· 2 days agoNot long ago, GameStop (NYSE:GME) stock soared and then tanked on the meme-stock waves. A company...